exo 1 Search Results


95
Chem Impex International syringe filter
Syringe Filter, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/syringe filter/product/Chem Impex International
Average 95 stars, based on 1 article reviews
syringe filter - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

92
Thermo Fisher gene exp exo1 hs01116190 m1
(A) A heatmap shows concentration-dependent changes of representative DNA repair-related genes. (B-E) Relative expression of <t>EXO1</t> (B), MRE11 (C), NEIL3 (D), and FANCB (E) was measured using real-time PCR in CBD-treated human Sertoli cells. The bar graphs show means ± SD (n=3). #, significant concentration-related linear trend. *, significantly different from the DMSO control.
Gene Exp Exo1 Hs01116190 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp exo1 hs01116190 m1/product/Thermo Fisher
Average 92 stars, based on 1 article reviews
gene exp exo1 hs01116190 m1 - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology exo1
Fig. 5 | BRCA1–BARD1 promotes resection by <t>EXO1</t> independently of CtIP. a, Representative kinetic resection assays with EXO1, RPA, in the absence or presence of BRCA1–BARD1. Top, a schematic of the assay. Red asterisks (*) represent the position of the radioactive labels. b, Quantitation of DNA degradation from assays such as shown in a. Averages shown; error bars, s.e.m.; n = 3. c, Cartoon of the primary structure of the EXO1 protein and the Δ1 variant used in the study. d, Resection assays with RPA, wild-type EXO1 or EXO1 Δ1, in the absence or presence of BRCA1–BARD1. Top, quantitation of DNA degradation. Averages shown; error bars, s.e.m.; n = 3. Bottom, representative assays. e, Representative protein-interaction assays. Top, a schematic of the assay. f, Quantitation of clonogenic cell survival of RPE1 cells EXO1+/+ or EXO1−/−
Exo1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exo1/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
exo1 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti exo1
Fig. 5 | BRCA1–BARD1 promotes resection by <t>EXO1</t> independently of CtIP. a, Representative kinetic resection assays with EXO1, RPA, in the absence or presence of BRCA1–BARD1. Top, a schematic of the assay. Red asterisks (*) represent the position of the radioactive labels. b, Quantitation of DNA degradation from assays such as shown in a. Averages shown; error bars, s.e.m.; n = 3. c, Cartoon of the primary structure of the EXO1 protein and the Δ1 variant used in the study. d, Resection assays with RPA, wild-type EXO1 or EXO1 Δ1, in the absence or presence of BRCA1–BARD1. Top, quantitation of DNA degradation. Averages shown; error bars, s.e.m.; n = 3. Bottom, representative assays. e, Representative protein-interaction assays. Top, a schematic of the assay. f, Quantitation of clonogenic cell survival of RPE1 cells EXO1+/+ or EXO1−/−
Anti Exo1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti exo1/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
anti exo1 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
Proteintech 16253 1 ap
Fig. 5 | BRCA1–BARD1 promotes resection by <t>EXO1</t> independently of CtIP. a, Representative kinetic resection assays with EXO1, RPA, in the absence or presence of BRCA1–BARD1. Top, a schematic of the assay. Red asterisks (*) represent the position of the radioactive labels. b, Quantitation of DNA degradation from assays such as shown in a. Averages shown; error bars, s.e.m.; n = 3. c, Cartoon of the primary structure of the EXO1 protein and the Δ1 variant used in the study. d, Resection assays with RPA, wild-type EXO1 or EXO1 Δ1, in the absence or presence of BRCA1–BARD1. Top, quantitation of DNA degradation. Averages shown; error bars, s.e.m.; n = 3. Bottom, representative assays. e, Representative protein-interaction assays. Top, a schematic of the assay. f, Quantitation of clonogenic cell survival of RPE1 cells EXO1+/+ or EXO1−/−
16253 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/16253 1 ap/product/Proteintech
Average 93 stars, based on 1 article reviews
16253 1 ap - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
Cusabio csb pa002455 cell signaling
Fig. 5 | BRCA1–BARD1 promotes resection by <t>EXO1</t> independently of CtIP. a, Representative kinetic resection assays with EXO1, RPA, in the absence or presence of BRCA1–BARD1. Top, a schematic of the assay. Red asterisks (*) represent the position of the radioactive labels. b, Quantitation of DNA degradation from assays such as shown in a. Averages shown; error bars, s.e.m.; n = 3. c, Cartoon of the primary structure of the EXO1 protein and the Δ1 variant used in the study. d, Resection assays with RPA, wild-type EXO1 or EXO1 Δ1, in the absence or presence of BRCA1–BARD1. Top, quantitation of DNA degradation. Averages shown; error bars, s.e.m.; n = 3. Bottom, representative assays. e, Representative protein-interaction assays. Top, a schematic of the assay. f, Quantitation of clonogenic cell survival of RPE1 cells EXO1+/+ or EXO1−/−
Csb Pa002455 Cell Signaling, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/csb pa002455 cell signaling/product/Cusabio
Average 90 stars, based on 1 article reviews
csb pa002455 cell signaling - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

96
Elabscience Biotechnology exo1
Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare <t>EXO1</t> expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.
Exo1, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exo1/product/Elabscience Biotechnology
Average 96 stars, based on 1 article reviews
exo1 - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology crispr cas9 ko plasmid
Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare <t>EXO1</t> expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.
Crispr Cas9 Ko Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr cas9 ko plasmid/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
crispr cas9 ko plasmid - by Bioz Stars, 2026-06
91/100 stars
  Buy from Supplier

93
Biorbyt pink
Sequences of primers used in qPCR
Pink, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pink/product/Biorbyt
Average 93 stars, based on 1 article reviews
pink - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
OriGene tr304725
Sequences of primers used in qPCR
Tr304725, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tr304725/product/OriGene
Average 90 stars, based on 1 article reviews
tr304725 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

95
Chem Impex International r 3 s 4 s 3 bromo 1 7 7 trimethylbicyclo 2 2 1 heptan 2 one
Sequences of primers used in qPCR
R 3 S 4 S 3 Bromo 1 7 7 Trimethylbicyclo 2 2 1 Heptan 2 One, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/r 3 s 4 s 3 bromo 1 7 7 trimethylbicyclo 2 2 1 heptan 2 one/product/Chem Impex International
Average 95 stars, based on 1 article reviews
r 3 s 4 s 3 bromo 1 7 7 trimethylbicyclo 2 2 1 heptan 2 one - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology selection exo1 shrna
Analyses of the <t> EXO1 </t> gene in 143 HCC tissues.
Selection Exo1 Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/selection exo1 shrna/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
selection exo1 shrna - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

Image Search Results


(A) A heatmap shows concentration-dependent changes of representative DNA repair-related genes. (B-E) Relative expression of EXO1 (B), MRE11 (C), NEIL3 (D), and FANCB (E) was measured using real-time PCR in CBD-treated human Sertoli cells. The bar graphs show means ± SD (n=3). #, significant concentration-related linear trend. *, significantly different from the DMSO control.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Article Title: Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells

doi: 10.1093/toxsci/kfac131

Figure Lengend Snippet: (A) A heatmap shows concentration-dependent changes of representative DNA repair-related genes. (B-E) Relative expression of EXO1 (B), MRE11 (C), NEIL3 (D), and FANCB (E) was measured using real-time PCR in CBD-treated human Sertoli cells. The bar graphs show means ± SD (n=3). #, significant concentration-related linear trend. *, significantly different from the DMSO control.

Article Snippet: To measure gene expression levels, real-time PCR assays were performed using FastStart Universal Probe Master (Rox, MilliporeSigma) and the following probes (Thermo Fisher Scientific): E2F1 (Hs00153451_m1), E2F7 (Hs00987777_m1), MCM3 (Hs00172459_m1), PRIM1 (Hs00265388_m1), POLE2 (Hs00160277_m1), POLD1 (Hs01100821_m1), CDC25A (Hs00947994_m1), CDKN1A (Hs00355782_m1), EXO1 (Hs01116190_m1), MRE11 (Hs00967437_m1), NEIL3 (Hs00217387_m1), FANCB (Hs00537483_m1), CDKN2A (Hs00923894_m1), IL-1A (Hs00174092_m1), IL-6 (Hs00174131_m1), and GAPDH (Hs02758991_g1).

Techniques: Concentration Assay, Expressing, Real-time Polymerase Chain Reaction, Control

Fig. 5 | BRCA1–BARD1 promotes resection by EXO1 independently of CtIP. a, Representative kinetic resection assays with EXO1, RPA, in the absence or presence of BRCA1–BARD1. Top, a schematic of the assay. Red asterisks (*) represent the position of the radioactive labels. b, Quantitation of DNA degradation from assays such as shown in a. Averages shown; error bars, s.e.m.; n = 3. c, Cartoon of the primary structure of the EXO1 protein and the Δ1 variant used in the study. d, Resection assays with RPA, wild-type EXO1 or EXO1 Δ1, in the absence or presence of BRCA1–BARD1. Top, quantitation of DNA degradation. Averages shown; error bars, s.e.m.; n = 3. Bottom, representative assays. e, Representative protein-interaction assays. Top, a schematic of the assay. f, Quantitation of clonogenic cell survival of RPE1 cells EXO1+/+ or EXO1−/−

Journal: Nature

Article Title: Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection.

doi: 10.1038/s41586-024-07909-9

Figure Lengend Snippet: Fig. 5 | BRCA1–BARD1 promotes resection by EXO1 independently of CtIP. a, Representative kinetic resection assays with EXO1, RPA, in the absence or presence of BRCA1–BARD1. Top, a schematic of the assay. Red asterisks (*) represent the position of the radioactive labels. b, Quantitation of DNA degradation from assays such as shown in a. Averages shown; error bars, s.e.m.; n = 3. c, Cartoon of the primary structure of the EXO1 protein and the Δ1 variant used in the study. d, Resection assays with RPA, wild-type EXO1 or EXO1 Δ1, in the absence or presence of BRCA1–BARD1. Top, quantitation of DNA degradation. Averages shown; error bars, s.e.m.; n = 3. Bottom, representative assays. e, Representative protein-interaction assays. Top, a schematic of the assay. f, Quantitation of clonogenic cell survival of RPE1 cells EXO1+/+ or EXO1−/−

Article Snippet: To test the interaction between BRCA1–BARD1 and WRN or EXO1, 1 μg of anti-BRCA1 antibody (Santa Cruz Biotechnology, sc-6954) or anti-WRN antibody (Cell Signaling, 4666S) were captured on 10 μl Protein G magnetic beads (Dynabeads, Invitrogen) by incubating at 4 °C for 1 h with gentle rotation in 50 μl of PBS-T (PBS with 0.1% Tween-20, Sigma).

Techniques: Quantitation Assay, Variant Assay

Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare EXO1 expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare EXO1 expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques: Gene Expression, RNA Sequencing, Expressing

High expression levels of PLCε and EXO1 in BCa tissues. (A, B) Disease free survival curves of BCa patients according to EXO1 and ATM mRNA levels in TCGA. (C) Representative haematoxyl in and eosin (H&E) staining and IHC staining in 72 BCa tissue samples and 24 corresponding adjacent non-neoplastic (BN) samples. Magnification × 200. Bars = 150 μm. H&E staining of bladder tissues were showed (a and i). Representative IHC staining of different staining intensities used as criteria in staining scoring: none staining was observed in BN (b-d), positive staining in BCa (j-l). PLCε localized in cytoplasm. EXO1 and ATM protein localized in nucleus. Images in the frame of (a-d and i-l) were enlarged to (e-h and m-p). (D-F) Average staining scores for PLCε, EXO1, and ATM expression in bladder tissues. (G, H) The correlation with PLCε and EXO1 expression and EXO1 and ATM expression in bladder tissues samples was analyzed by Pearson analysis. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: High expression levels of PLCε and EXO1 in BCa tissues. (A, B) Disease free survival curves of BCa patients according to EXO1 and ATM mRNA levels in TCGA. (C) Representative haematoxyl in and eosin (H&E) staining and IHC staining in 72 BCa tissue samples and 24 corresponding adjacent non-neoplastic (BN) samples. Magnification × 200. Bars = 150 μm. H&E staining of bladder tissues were showed (a and i). Representative IHC staining of different staining intensities used as criteria in staining scoring: none staining was observed in BN (b-d), positive staining in BCa (j-l). PLCε localized in cytoplasm. EXO1 and ATM protein localized in nucleus. Images in the frame of (a-d and i-l) were enlarged to (e-h and m-p). (D-F) Average staining scores for PLCε, EXO1, and ATM expression in bladder tissues. (G, H) The correlation with PLCε and EXO1 expression and EXO1 and ATM expression in bladder tissues samples was analyzed by Pearson analysis. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques: Expressing, Staining, Immunohistochemistry

Correlation between PLCε,  EXO1  and ATM expressions and the corresponding clinicopathological parameter in BCa patients

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: Correlation between PLCε, EXO1 and ATM expressions and the corresponding clinicopathological parameter in BCa patients

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques:

A association between PLCε and EXO1 expression in BCa patients. A. PLCε and EXO1 protein expression in 24 BCa tissue samples (T) and 24 BN samples (N) were assayed by western blotting analysis. B, C. PLCε and EXO1 protein expression in tissues were quantified as mean optical density by Image J software. D, E. PLCε and EXO1 protein expression in tissues were assayed by Statistical analysis. F. Correlation curve of PLCε protein versus corresponding EXO1 by Statistical analysis. G. Western blotting analysis detected the expression of PLCε and EXO1 in two human BCa cell lines and SV-HUC-1 cells. H, I. Detection of PLCε and EXO1 by qPCR. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: A association between PLCε and EXO1 expression in BCa patients. A. PLCε and EXO1 protein expression in 24 BCa tissue samples (T) and 24 BN samples (N) were assayed by western blotting analysis. B, C. PLCε and EXO1 protein expression in tissues were quantified as mean optical density by Image J software. D, E. PLCε and EXO1 protein expression in tissues were assayed by Statistical analysis. F. Correlation curve of PLCε protein versus corresponding EXO1 by Statistical analysis. G. Western blotting analysis detected the expression of PLCε and EXO1 in two human BCa cell lines and SV-HUC-1 cells. H, I. Detection of PLCε and EXO1 by qPCR. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques: Expressing, Western Blot, Software

PLCε depletion inhibit cell proliferation, induce G1 phase cell cycle arrest, apoptosis and cisplatin sensitivity. A. The T24 and BIU-87 cells were infected with adenovirus sh-PLCε, western blotting were detected the expression of PLCε. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX. C, D. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. E-K. The T24 and BIU-87 cells were infected with vector-EXO1 for 72 h. E, F. Representative flow cytometry analysis of cell apoptosis after 72 h of culture in Ad-shPLCε or/and EXO1 groups. G, H. Clone formation analysis was employed to test the cell proliferation in Ad-shPLCε or/and EXO1 groups. I. IC50 values were measured by CCK-8 to compare the susceptibility of the three cell lines to cisplatin. J, K. IC50 values of T24 and BIU were measured by CCK-8 Analysis in Ad-shPLCε or/and EXO1 groups. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: PLCε depletion inhibit cell proliferation, induce G1 phase cell cycle arrest, apoptosis and cisplatin sensitivity. A. The T24 and BIU-87 cells were infected with adenovirus sh-PLCε, western blotting were detected the expression of PLCε. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX. C, D. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. E-K. The T24 and BIU-87 cells were infected with vector-EXO1 for 72 h. E, F. Representative flow cytometry analysis of cell apoptosis after 72 h of culture in Ad-shPLCε or/and EXO1 groups. G, H. Clone formation analysis was employed to test the cell proliferation in Ad-shPLCε or/and EXO1 groups. I. IC50 values were measured by CCK-8 to compare the susceptibility of the three cell lines to cisplatin. J, K. IC50 values of T24 and BIU were measured by CCK-8 Analysis in Ad-shPLCε or/and EXO1 groups. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques: Infection, Western Blot, Expressing, Flow Cytometry, Plasmid Preparation, CCK-8 Assay

PLCε regulates EXO1-mediated cell cycle, proliferation and apoptosis through nuclear translocation of p-ATM. A. The BCa cells were infected with vector-shEXO1, western blotting detected the expression of EXO1. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9, and BAX in sh-NC and sh-EXO1 groups. C. The BCa cells were infected with vector-EXO1, western blotting detected the expression of EXO1. D. Western blotting analysis detected the expression of PLCε, EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX in sh-EXO1 groups or/and Ad-shPLCε groups. E. Detection of p-ATM expression in nuclear and cytoplasm by western blot. F. Western blotting analysis showing that Ad-shPLCε reduced EXO1 level with 13 nM KU-55933 for 48 h. G. Immunofluorescence staining analysis demonstrating that Ad-shPLCε disrupted p-ATM nuclear translocation stimulated by cisplatin. Magnification: 400×. Bars = 100 μm. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: PLCε regulates EXO1-mediated cell cycle, proliferation and apoptosis through nuclear translocation of p-ATM. A. The BCa cells were infected with vector-shEXO1, western blotting detected the expression of EXO1. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9, and BAX in sh-NC and sh-EXO1 groups. C. The BCa cells were infected with vector-EXO1, western blotting detected the expression of EXO1. D. Western blotting analysis detected the expression of PLCε, EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX in sh-EXO1 groups or/and Ad-shPLCε groups. E. Detection of p-ATM expression in nuclear and cytoplasm by western blot. F. Western blotting analysis showing that Ad-shPLCε reduced EXO1 level with 13 nM KU-55933 for 48 h. G. Immunofluorescence staining analysis demonstrating that Ad-shPLCε disrupted p-ATM nuclear translocation stimulated by cisplatin. Magnification: 400×. Bars = 100 μm. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques: Translocation Assay, Infection, Plasmid Preparation, Western Blot, Expressing, Immunofluorescence, Staining

PLCε depletion enhanced the inhibitory effect of cisplatin on the growth of BCa cells. C-I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. A, B. Western blotting analysis showing the expressions of EXO1 and γ-H2AX stimulated by cisplatin at different concentrations (for 24 h) and different treat times (with 8 μg/mL) in BCa cells. C. Morphological change of bladder cancer cells with cisplatin or (and) Ad-shPLCε treatment. Magnification: 200×. Bars = 100 μm. D, E. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. F. Western blotting detected the expression of cell cycle and proliferation related proteins. G, H. Clone formation analysis was employed to test the cell proliferation of BCa cell lines after treatment with cisplatin. I. Western blotting detected the expression of cell apoptosis related proteins. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: PLCε depletion enhanced the inhibitory effect of cisplatin on the growth of BCa cells. C-I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. A, B. Western blotting analysis showing the expressions of EXO1 and γ-H2AX stimulated by cisplatin at different concentrations (for 24 h) and different treat times (with 8 μg/mL) in BCa cells. C. Morphological change of bladder cancer cells with cisplatin or (and) Ad-shPLCε treatment. Magnification: 200×. Bars = 100 μm. D, E. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. F. Western blotting detected the expression of cell cycle and proliferation related proteins. G, H. Clone formation analysis was employed to test the cell proliferation of BCa cell lines after treatment with cisplatin. I. Western blotting detected the expression of cell apoptosis related proteins. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques: Western Blot, Flow Cytometry, Expressing

Decreased levels of serum miR-145 in BCa patients and PLCε was a direct target of miR-145 in BCa cells. A. Comparison of miR-145 levels in three cell lines by qPCR. vs SV-HUC-1. B. Expression levels of miR-145 in T24 and BIU cells transfected with miR-145 mimics and NC. C, D. PLCε mRNA and protein expression levels in the BCa cell lines detected by qRT-PCR and western blotting after transfection with miR-145 mimics. E. Schematic representation of the predicted miR-145 binding sites in 3’UTR of PLCε. F. Wild-type or mutant 3’UTR of PLCε gene reporter plasmid was co-transfected with miR-145mimics or NC into T24, followed by luciferase reporter assays. vs miR-NC. G. Changes of PLCε expression analysised by qPCR in BCa cells after treating with cisplatin or (and) miR-145. H, I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. H. Viability of BCa cells with cisplatin or (and) miR-145 mimics treatment detected by CCK-8. I. Western blotting analysis showing the expression of PLCε, EXO1, and γH2AX after cisplatin or (and) miR-145 mimics treatment for 48 h. J. The serum miR-145 expression in 40 patients with BCa, 19 patients with urinary benign diseases (BBD) and 21 healthy controls (Normal) were obtained by qPCR. Expression levels of miR-145 were normalized to U6. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: Decreased levels of serum miR-145 in BCa patients and PLCε was a direct target of miR-145 in BCa cells. A. Comparison of miR-145 levels in three cell lines by qPCR. vs SV-HUC-1. B. Expression levels of miR-145 in T24 and BIU cells transfected with miR-145 mimics and NC. C, D. PLCε mRNA and protein expression levels in the BCa cell lines detected by qRT-PCR and western blotting after transfection with miR-145 mimics. E. Schematic representation of the predicted miR-145 binding sites in 3’UTR of PLCε. F. Wild-type or mutant 3’UTR of PLCε gene reporter plasmid was co-transfected with miR-145mimics or NC into T24, followed by luciferase reporter assays. vs miR-NC. G. Changes of PLCε expression analysised by qPCR in BCa cells after treating with cisplatin or (and) miR-145. H, I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. H. Viability of BCa cells with cisplatin or (and) miR-145 mimics treatment detected by CCK-8. I. Western blotting analysis showing the expression of PLCε, EXO1, and γH2AX after cisplatin or (and) miR-145 mimics treatment for 48 h. J. The serum miR-145 expression in 40 patients with BCa, 19 patients with urinary benign diseases (BBD) and 21 healthy controls (Normal) were obtained by qPCR. Expression levels of miR-145 were normalized to U6. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques: Comparison, Expressing, Transfection, Quantitative RT-PCR, Western Blot, Binding Assay, Mutagenesis, Plasmid Preparation, Luciferase, CCK-8 Assay

A mechanism for PLCε depletion-mediated cisplatin sensitivity of BCa. Schematic diagram describing the functional significance of PLCε in BCa cells. PLCε regulate EXO1 medicated-cell cycle, proliferation, apoptosis and cisplatin sensitivity through nuclear translocation of p-ATM and can be regulated by miR-145.

Journal: American Journal of Cancer Research

Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

doi:

Figure Lengend Snippet: A mechanism for PLCε depletion-mediated cisplatin sensitivity of BCa. Schematic diagram describing the functional significance of PLCε in BCa cells. PLCε regulate EXO1 medicated-cell cycle, proliferation, apoptosis and cisplatin sensitivity through nuclear translocation of p-ATM and can be regulated by miR-145.

Article Snippet: The following primary antibodies were used: polyclonal rabbit antibody against PLCε (Santa Cruz, dilution 1:50), EXO1 (Elabscience, dilution 1:100), ATM (Abcam, 1:100).

Techniques: Functional Assay, Translocation Assay

Sequences of primers used in qPCR

Journal: Journal of Cellular and Molecular Medicine

Article Title: 5‐Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy

doi: 10.1111/jcmm.13914

Figure Lengend Snippet: Sequences of primers used in qPCR

Article Snippet: Next, the membrane was washed with TBST and incubated overnight with primary antibody for: mitofusin 1 (MFN) (orb11040; Biorbyt, Cambridge, UK), PINK (orb331233; Biorbyt), caspase‐3 (437800; Life Technologies), beta‐actin (A5441; Sigma‐Aldrich) and mitochondrial fision factor ‐MFF (orb325479; Biorbyt) at a dilution of 1:500.

Techniques: Sequencing, Amplification

AZA / RES treatment improved mitochondrial condition and reduced ROS accumulation in ASC EMS . To investigate oxidative stress in cells, they were culture for 24 hours in control or experimental conditions and subjected to further analysis. MMP was measured using JC ‐1 probe by flow cytometry (A). MMP depolarization in ASC EMS was markedly reversed in ASC EMS II (B). Intracellular ROS level was stained with H2 DCFDA and detected by flow cytometry. Results were respectively shown in the histograms (A). AZA / RES treatment significantly reduced ROS production in ASC EMS (C). Antioxidative properties of cells were analyzed by spectrophotometric measurement of SOD activity (D). ASC EMS II displayed enhanced enzyme activity. Using RT ‐ PCR amount of miR‐24 was evaluated (E). TEM analysis showed ultrastructural changes in mitochondria morphology in ASC EMS and it reversal after AZA / RES treatment (F). Boxed regions were magnified and showed on the left side. Based on representative photographs, quantification of aberrant mitochondria was performed (G). Mitochondrial fission was examined using RT ‐ PCR for FIS (H) while mitophagy was established by measuring the expression of PINK (I) and PARKIN (J). Moreover, we established that AZA / RES diminished expression of Mief1 (K) and Mief2 (L). Furthermore, using western blot amount of MFF , MNF , PINK were investigated (M). In treated cells, AZA / RES mitigated both, mitochondrial division and mitophagy. Scale bars: 1 μm. Results expressed as mean ± SD . Statistical significance indicated as asterisk (*) when comparing the result to ASC CTRL , and as hashtag (#) when comparing to ASC EMS . # P < 0.05; ##, ** P < 0.01; ###, *** P < 0.001

Journal: Journal of Cellular and Molecular Medicine

Article Title: 5‐Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy

doi: 10.1111/jcmm.13914

Figure Lengend Snippet: AZA / RES treatment improved mitochondrial condition and reduced ROS accumulation in ASC EMS . To investigate oxidative stress in cells, they were culture for 24 hours in control or experimental conditions and subjected to further analysis. MMP was measured using JC ‐1 probe by flow cytometry (A). MMP depolarization in ASC EMS was markedly reversed in ASC EMS II (B). Intracellular ROS level was stained with H2 DCFDA and detected by flow cytometry. Results were respectively shown in the histograms (A). AZA / RES treatment significantly reduced ROS production in ASC EMS (C). Antioxidative properties of cells were analyzed by spectrophotometric measurement of SOD activity (D). ASC EMS II displayed enhanced enzyme activity. Using RT ‐ PCR amount of miR‐24 was evaluated (E). TEM analysis showed ultrastructural changes in mitochondria morphology in ASC EMS and it reversal after AZA / RES treatment (F). Boxed regions were magnified and showed on the left side. Based on representative photographs, quantification of aberrant mitochondria was performed (G). Mitochondrial fission was examined using RT ‐ PCR for FIS (H) while mitophagy was established by measuring the expression of PINK (I) and PARKIN (J). Moreover, we established that AZA / RES diminished expression of Mief1 (K) and Mief2 (L). Furthermore, using western blot amount of MFF , MNF , PINK were investigated (M). In treated cells, AZA / RES mitigated both, mitochondrial division and mitophagy. Scale bars: 1 μm. Results expressed as mean ± SD . Statistical significance indicated as asterisk (*) when comparing the result to ASC CTRL , and as hashtag (#) when comparing to ASC EMS . # P < 0.05; ##, ** P < 0.01; ###, *** P < 0.001

Article Snippet: Next, the membrane was washed with TBST and incubated overnight with primary antibody for: mitofusin 1 (MFN) (orb11040; Biorbyt, Cambridge, UK), PINK (orb331233; Biorbyt), caspase‐3 (437800; Life Technologies), beta‐actin (A5441; Sigma‐Aldrich) and mitochondrial fision factor ‐MFF (orb325479; Biorbyt) at a dilution of 1:500.

Techniques: Control, Flow Cytometry, Staining, Activity Assay, Reverse Transcription Polymerase Chain Reaction, Expressing, Western Blot

AZA / RES diminish apoptosis and autophagy in ASC EMS by the inhibition of mitochondrial fission. In order to uncover the mechanism underlying AZA / RES beneficial effects on cells, they were cultured in control, AZA / RES and/or mitochondrial division inhibitor‐ MDIVI ‐, supplemented medium. After 24 hours of propagation cells were subjected to RT ‐ PCR , TEM and confocal analysis. Using RT ‐ PCR expression of p53 (A), p21 (B), p62 (C), PINK (D) and MFN (E) was analyzed. Mitochondrial dynamics and morphology of mitochondrial net were further visualized using TEM and confocal microscope (MitoRed staining) (F). Boxed regions were enlarged and presented below MitoRed staining to visualize shape of mitochondrial network. Obtained results indicated that beneficial effects of AZA / RES result from inhibition of mitochondrial fission and modulation of autophagy in treated cells. Scale bars: TEM : 5 μm, confocal: 20 μm. Results expressed as mean ± SD . Statistical significance indicated as asterisk (*) when comparing the result to ASC CTRL , and as hashtag (#) when comparing to ASC EMS . #, * P < 0.05; ##, ** P < 0.01; ###, *** P < 0.001

Journal: Journal of Cellular and Molecular Medicine

Article Title: 5‐Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy

doi: 10.1111/jcmm.13914

Figure Lengend Snippet: AZA / RES diminish apoptosis and autophagy in ASC EMS by the inhibition of mitochondrial fission. In order to uncover the mechanism underlying AZA / RES beneficial effects on cells, they were cultured in control, AZA / RES and/or mitochondrial division inhibitor‐ MDIVI ‐, supplemented medium. After 24 hours of propagation cells were subjected to RT ‐ PCR , TEM and confocal analysis. Using RT ‐ PCR expression of p53 (A), p21 (B), p62 (C), PINK (D) and MFN (E) was analyzed. Mitochondrial dynamics and morphology of mitochondrial net were further visualized using TEM and confocal microscope (MitoRed staining) (F). Boxed regions were enlarged and presented below MitoRed staining to visualize shape of mitochondrial network. Obtained results indicated that beneficial effects of AZA / RES result from inhibition of mitochondrial fission and modulation of autophagy in treated cells. Scale bars: TEM : 5 μm, confocal: 20 μm. Results expressed as mean ± SD . Statistical significance indicated as asterisk (*) when comparing the result to ASC CTRL , and as hashtag (#) when comparing to ASC EMS . #, * P < 0.05; ##, ** P < 0.01; ###, *** P < 0.001

Article Snippet: Next, the membrane was washed with TBST and incubated overnight with primary antibody for: mitofusin 1 (MFN) (orb11040; Biorbyt, Cambridge, UK), PINK (orb331233; Biorbyt), caspase‐3 (437800; Life Technologies), beta‐actin (A5441; Sigma‐Aldrich) and mitochondrial fision factor ‐MFF (orb325479; Biorbyt) at a dilution of 1:500.

Techniques: Inhibition, Cell Culture, Control, Reverse Transcription Polymerase Chain Reaction, Expressing, Microscopy, Staining

Analyses of the  EXO1  gene in 143 HCC tissues.

Journal: Cell Cycle

Article Title: EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients

doi: 10.1080/15384101.2018.1534511

Figure Lengend Snippet: Analyses of the EXO1 gene in 143 HCC tissues.

Article Snippet: ShRNA, cell transfection and selection Exo1 shRNA (sc-44,880-SH) and its negative control carrying an irrelevant nucleotide (sc-108,060) were purchased from Santa Cruz Biotechnology (California, USA).

Techniques:

Univariate and multivariate Cox regression analyses of  EXO1  mRNA expression and clinical variables for overall survival in HCC patients.

Journal: Cell Cycle

Article Title: EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients

doi: 10.1080/15384101.2018.1534511

Figure Lengend Snippet: Univariate and multivariate Cox regression analyses of EXO1 mRNA expression and clinical variables for overall survival in HCC patients.

Article Snippet: ShRNA, cell transfection and selection Exo1 shRNA (sc-44,880-SH) and its negative control carrying an irrelevant nucleotide (sc-108,060) were purchased from Santa Cruz Biotechnology (California, USA).

Techniques: Expressing